APA aipamena

Luo, C., Wu, G., Huang, X., Ma, Y., Zhang, Y., Song, Q., . . . Li, X. (2021). Efficacy and safety of new anti-CD20 monoclonal antibodies versus rituximab for induction therapy of CD20(+) B-cell non-Hodgkin lymphomas: A systematic review and meta-analysis. Sci Rep.

Chicago Style aipamena

Luo, Chengxin, et al. "Efficacy and Safety of New Anti-CD20 Monoclonal Antibodies Versus Rituximab for Induction Therapy of CD20(+) B-cell Non-Hodgkin Lymphomas: A Systematic Review and Meta-analysis." Sci Rep 2021.

MLA aipamena

Luo, Chengxin, et al. "Efficacy and Safety of New Anti-CD20 Monoclonal Antibodies Versus Rituximab for Induction Therapy of CD20(+) B-cell Non-Hodgkin Lymphomas: A Systematic Review and Meta-analysis." Sci Rep 2021.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.